PREDICTORS OF CYTOMEGALOVIRUS DISEASE, NATURAL-HISTORY AND AUTOPSY FINDINGS IN A COHORT OF PATIENTS WITH AIDS

Citation
Ad. Monforte et al., PREDICTORS OF CYTOMEGALOVIRUS DISEASE, NATURAL-HISTORY AND AUTOPSY FINDINGS IN A COHORT OF PATIENTS WITH AIDS, AIDS, 11(4), 1997, pp. 517-524
Citations number
35
Categorie Soggetti
Immunology,"Infectious Diseases
Journal title
AIDSACNP
ISSN journal
02699370
Volume
11
Issue
4
Year of publication
1997
Pages
517 - 524
Database
ISI
SICI code
0269-9370(1997)11:4<517:POCDNA>2.0.ZU;2-Q
Abstract
Objective: To identify the predictors of acquiring cytomegalovirus (CM V) disease, and to describe natural history, therapeutic management an d autopsy findings in affected patients. Design: Observational study o f a consecutive cohort of AIDS patients diagnosed and followed in the same institution. Methods: All of the patients with CMV disease were i ncluded. Statistical analyses were performed to establish the risk of acquiring the disease at or after AIDS presentation, survival, and the occurrence and lime of relapses in relation to maintenance therapy. T he presence of CMV infection at autopsy was also investigated. Results : CMV disease was diagnosed in 304 (24.8%) out of 1227 patients, its i ncidence increasing according to the year of AIDS diagnosis. Women, ho mosexual men, patients given zidovudine and Pneumocystis carinii pneum onia (PCP) prophylaxis before AIDS, and severely immunodepressed patie nts were at higher risk for the disease. CMV disease was an independen t factor of worse survival (hazard ratio, 1.7 versus PCP; 95% confiden ce intervals, 1.28-2.13). Patients untreated during the acute phase ha d a 4.3 higher risk of dying than those treated. Relapses occurred les s frequently and later in patients given continuous maintenance treatm ent (23 out of 113; 17 months) than in untreated patients (13 out of 1 6; 3 months) or those given discontinuous therapy (22 out of 40; 7 mon ths), whereas survival was independent from treatment. CMV infection w as found in 97 out of 134 patients at autopsy, but was unassociated wi th relapse. Conclusions: CMV is a severe disease whose frequency is hi gher in severely immunodepressed patients. Continuous treatment leads to a lower relapse rate even if it does not change survival or eradica te the infection.